Mark Damian Tattoli's most recent trade in Core Laboratories N.V. was a trade of 250 Common Stock done . Disclosure was reported to the exchange on May 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 250 | 16,242 (0%) | 0% | 0 | Common Stock | |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 250 | 2,400 | - | - | Restricted Shares | |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 200 | 16,071 (0%) | 0% | 0 | Common Stock | |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 200 | 2,650 | - | - | Restricted Shares | |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.68 per share. | 01 May 2025 | 99 | 16,143 (0%) | 0% | 11.7 | 1,156 | Common Stock |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.68 per share. | 01 May 2025 | 79 | 15,992 (0%) | 0% | 11.7 | 923 | Common Stock |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 32,912 | 32,912 | - | - | Performance Shares | |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2024 | 9,604 | 0 | - | - | Performance Shares | |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2024 | 9,604 | 20,899 (0%) | 0% | 0 | Common Stock | |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.31 per share. | 31 Dec 2024 | 5,028 | 15,871 (0%) | 0% | 17.3 | 87,035 | Common Stock |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2024 | 700 | 2,850 | - | - | Restricted Shares | |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2024 | 700 | 11,571 (0%) | 0% | 0 | Common Stock | |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.21 per share. | 01 Oct 2024 | 276 | 11,295 (0%) | 0% | 19.2 | 5,302 | Common Stock |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2024 | 250 | 10,970 (0%) | 0% | 0 | Common Stock | |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2024 | 250 | 3,550 | - | - | Restricted Shares | |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2024 | 120 | 3,800 | - | - | Restricted Shares | |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2024 | 120 | 10,768 (0%) | 0% | 0 | Common Stock | |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.24 per share. | 01 Aug 2024 | 99 | 10,871 (0%) | 0% | 23.2 | 2,301 | Common Stock |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.25 per share. | 01 Aug 2024 | 48 | 10,720 (0%) | 0% | 23.3 | 1,116 | Common Stock |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 250 | 3,920 | - | - | Restricted Shares | |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 250 | 10,747 (0%) | 0% | 0 | Common Stock | |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 200 | 4,170 | - | - | Restricted Shares | |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 200 | 10,576 (0%) | 0% | 0 | Common Stock | |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.71 per share. | 01 May 2024 | 99 | 10,648 (0%) | 0% | 15.7 | 1,555 | Common Stock |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.71 per share. | 01 May 2024 | 79 | 10,497 (0%) | 0% | 15.7 | 1,241 | Common Stock |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 21,418 | 21,418 | - | - | Performance Shares | |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2022 | 160 | 5,228 (0%) | 0% | 0 | Common Shares | |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2022 | 160 | 6,050 | - | - | Restricted Shares | |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.51 per share. | 01 Dec 2022 | 63 | 5,165 (0%) | 0% | 21.5 | 1,355 | Common Shares |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2022 | 700 | 5,344 (0%) | 0% | 0 | Common Shares | |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2022 | 700 | 6,210 | - | - | Restricted Shares | |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.48 per share. | 01 Oct 2022 | 276 | 5,068 (0%) | 0% | 13.5 | 3,720 | Common Shares |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2022 | 250 | 4,756 (0%) | 0% | 0 | Common Shares | |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2022 | 250 | 6,910 | - | - | Restricted Shares | |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2022 | 120 | 7,160 | - | - | Restricted Shares | |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2022 | 120 | 4,560 (0%) | 0% | 0 | Common Shares | |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.02 per share. | 01 Aug 2022 | 112 | 4,644 (0%) | 0% | 18.0 | 2,018 | Common Shares |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.02 per share. | 01 Aug 2022 | 54 | 4,506 (0%) | 0% | 18.0 | 973 | Common Shares |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2022 | 250 | 7,280 | - | - | Restricted Shares | |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2022 | 250 | 4,537 (0%) | 0% | 0 | Common Shares | |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2022 | 200 | 4,364 (0%) | 0% | 0 | Common Shares | |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2022 | 200 | 7,530 | - | - | Restricted Shares | |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.00 per share. | 01 May 2022 | 97 | 4,440 (0%) | 0% | 26 | 2,522 | Common Shares |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.00 per share. | 01 May 2022 | 77 | 4,287 (0%) | 0% | 26 | 2,002 | Common Shares |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 110 | 7,730 | - | - | Restricted Shares | |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 110 | 4,214 (0%) | 0% | 0 | Common Shares | |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.52 per share. | 01 Mar 2022 | 50 | 4,164 (0%) | 0% | 27.5 | 1,376 | Common Shares |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 17,588 | 17,588 | - | - | Performance Shares | |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2021 | 160 | 4,143 (0%) | 0% | 0 | Common Shares | |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2021 | 160 | 7,840 | - | - | Restricted Shares | |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.41 per share. | 01 Dec 2021 | 39 | 4,104 (0%) | 0% | 22.4 | 874 | Common Shares |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2021 | 7,320 | 7,320 | - | - | Restricted Shares | |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2021 | 6,900 | 6,900 | - | - | Performance Shares | |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2021 | 1,500 | 8,700 | - | - | Restricted Shares | |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jul 2021 | 700 | 8,000 | - | - | Restricted Shares | |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jul 2021 | 700 | 4,152 (0%) | 0% | 0 | Common Shares | |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.05 per share. | 02 Jul 2021 | 169 | 3,983 (0%) | 0% | 29.0 | 4,909 | Common Shares |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jul 2021 | 120 | 3,480 (0%) | 0% | 0 | Common Shares | |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jul 2021 | 120 | 7,200 | - | - | Restricted Shares | |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.34 per share. | 02 Jul 2021 | 29 | 3,451 (0%) | 0% | 33.3 | 967 | Common Shares |
| Core Laboratories N.V. | Mark Damian Tattoli | SVP, Gen Counsel & Secretary | Other type of transaction at price $ 0.00 per share. | 02 Jul 2021 | 1 | 3,452 (0%) | 0% | 0 | Common Shares |